Skelebenz 15 Capsule
1 Strip of 10 Capsules.Prescription required
About this product:
| Salt Composition: | Cyclobenzaprine (15mg) |
| Manufacturer: | Sun Pharmaceutical Industries Ltd |
| Storage: | Below 25 degree celcius |
In Stock
Have doubts about this medicine?
Have doubts about this medicine?
Skelebenz 15 Capsule ER is a muscle relaxer that provides relief from discomfort associated with acute, painful musculoskeletal conditions such as rigidity, tension, stiffness, and muscle spasms. Skelebenz 15 Capsule ER should be taken with food to prevent upset stomach. It is recommended to use the smallest amount necessary to control symptoms for the shortest possible time. Take this medicine regularly while you need it, and try not to miss doses as this will make the medicine less effective. Some common side effects include sleepiness, dryness in the mouth, tiredness, and headache.
Skelebenz 15 Capsule ER is a muscle relaxant that works on the centres in the brain and spinal cord to relieve muscle stiffness or spasm without reduction in strength. This improves pain and movement of muscles.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Skelebenz 15 Capsule ER is to be taken with food.
- Take it with or after food or a glass of milk.
- Do not drive or do anything requiring concentration until you know how it affects you.
- Avoid consuming alcohol when taking Skelebenz 15 Capsule ER as it may cause excessive drowsiness.
- Inform your doctor if you are pregnant, planning to conceive, or breastfeeding.
- Do not stop taking it suddenly without talking to your doctor if you've been on it for a long time.
Alcohol
Skelebenz 15 Capsule ER may cause excessive drowsiness with alcohol.
Breastfeed
Skelebenz 15 Capsule ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Skelebenz 15 Capsule ER is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
